Literature DB >> 7886646

Variability of peak expiratory flow rate in children: short and long term reproducibility.

T Frischer1, R Meinert, R Urbanek, J Kuehr.   

Abstract

BACKGROUND: Variability of peak expiratory flow (PEF) has been proposed as a surrogate for bronchial hyperresponsiveness. The normal range of variability of PEF for children has been reported and the test has been used to screen for asthma in population based studies. However, there is little information on the reproducibility of the method in epidemiological settings.
METHODS: In a cohort study of primary school children the variability in PEF was recorded in two consecutive years for one week (first survey) and two weeks (second survey) using mini Wright peak flow meters. PEF was recorded twice daily (morning and evening) and average amplitude as a percentage of mean was calculated as a standard measure of PEF variability for each single week of PEF measurement. Children with PEF variability exceeding the 90% percentile of the distribution for the specific time period were regarded as having increased variability of PEF.
RESULTS: Of 66 children with increased PEF variability in the first year, 13 (19.7%) had an abnormal test in the first week of the second year. Of 543 children with normal PEF variability in the first year, 44 (8.1%) had an abnormal test in the second study year (odds ratio 2.8, confidence interval (CI) 1.4 to 5.4). Of 646 children in the second survey 61 (9.4%) were abnormal during the first week and 68 (10.5%) had an increased PEF variability during the second week, but only 24 (3.7%) children had an increased PEF variability in both weeks. The sensitivity (specificity) for doctor-diagnosed asthma (12 month period prevalence) was 36.4% (91.0%) in the first week of the second survey. When measurements of both weeks of the second survey were used to calculate PEF variability there was little improvement in the sensitivity (38.1%) and specificity (91.5%), mainly because of decreased compliance in the second measurement week.
CONCLUSIONS: In young children assessment of PEF variability in order to screen for asthma is of limited value because of the low reproducibility of the method.

Entities:  

Mesh:

Year:  1995        PMID: 7886646      PMCID: PMC473702          DOI: 10.1136/thx.50.1.35

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Circadian rhythm of peak expiratory flow in asthmatic and normal children.

Authors:  A J Henderson; F Carswell
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

2.  Repeatability of ventilatory function measurements in a population survey of 7 year old children.

Authors:  D P Strachan
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

3.  Diurnal variation of peak expiratory flow rate in asthmatic children.

Authors:  P D Sly; M E Hibbert; L I Landau
Journal:  Pediatr Pulmonol       Date:  1986 May-Jun

4.  Validation of morning dip of peak expiratory flow as an indicator of the severity of nocturnal asthma.

Authors:  V Bellia; A Visconti; G Insalaco; G Cuttitta; G Ferrara; G Bonsignore
Journal:  Chest       Date:  1988-07       Impact factor: 9.410

5.  Variability of peak flow in wheezy children.

Authors:  I Johnston; H R Anderson; S Patel
Journal:  Thorax       Date:  1984-08       Impact factor: 9.139

6.  Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study.

Authors:  L K Josephs; I Gregg; M A Mullee; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1989-08

7.  Influence of skin prick test criteria on estimation of prevalence and incidence of allergic sensitization in children.

Authors:  R Meinert; T Frischer; W Karmaus; J Kuehr
Journal:  Allergy       Date:  1994-08       Impact factor: 13.146

8.  Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate.

Authors:  M R Hetzel; T J Clark
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

9.  Variation in peak expiratory flow of normal and asymptomatic asthmatic children.

Authors:  M Albertini; S Politano; E Berard; P Boutte; R Mariani
Journal:  Pediatr Pulmonol       Date:  1989

Review 10.  Airway hyperresponsiveness: therapeutic implications.

Authors:  D W Cockcroft
Journal:  Ann Allergy       Date:  1987-12
View more
  7 in total

Review 1.  The pharmacogenetics of asthma treatment.

Authors:  Kelan Tantisira; Scott Weiss
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

2.  Longitudinal study of free running exercise challenge: reproducibility.

Authors:  C V Powell; R D White; R A Primhak
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

Review 3.  The pharmacogenetics and pharmacogenomics of asthma therapy.

Authors:  S M Tse; K Tantisira; S T Weiss
Journal:  Pharmacogenomics J       Date:  2011-10-11       Impact factor: 3.550

4.  Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.

Authors:  P L Brand; E J Duiverman; H J Waalkens; E E van Essen-Zandvliet; K F Kerrebijn
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

5.  Longitudinal validation of a tool for asthma self-monitoring.

Authors:  Flory L Nkoy; Bryan L Stone; Bernhard A Fassl; Derek A Uchida; Karmella Koopmeiners; Sarah Halbern; Eun H Kim; Allison Wilcox; Jian Ying; Tom H Greene; David M Mosen; Michael N Schatz; Christopher G Maloney
Journal:  Pediatrics       Date:  2013-11-11       Impact factor: 7.124

6.  Development of a novel tool for engaging children and parents in asthma self-management.

Authors:  Flory L Nkoy; Bryan L Stone; Bernhard A Fassl; Karmella Koopmeiners; Sarah Halbern; Eun H Kim; Justin Poll; Joseph W Hales; Dillon Lee; Christopher G Maloney
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

7.  Predicting asthma control deterioration in children.

Authors:  Gang Luo; Bryan L Stone; Bernhard Fassl; Christopher G Maloney; Per H Gesteland; Sashidhar R Yerram; Flory L Nkoy
Journal:  BMC Med Inform Decis Mak       Date:  2015-10-14       Impact factor: 2.796

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.